The European transplant diagnostics market is growing steadily and is anticipated to showcase a CAGR of 6.57% from 2023 to 2028. As a result, the market size in this region is expected to grow from USD 1.2 billion in 2023 to USD 1.65 billion by 2028.
The growing number of organ transplant procedures in Europe is a significant factor driving the European transplant diagnostics market forward. An increase in the number of centers that do transplantations has been noticed in Europe, and the awareness among people regarding transplantations is also growing; such factors are expected to boost the transplant diagnostics market in Europe. As per the Council of Europe, in 2021, 36,000 patients had transplanted organs, and an estimated 41000 new patients are on the waiting list and did registration. In addition, the growing number of organ transplantation procedures and increasing success rate are anticipated to support the growth rate of the European transplant diagnostics market. Checking whether the organ donated by the donor is suitable for the receptor body before transplantation is the main thing for the patient's survival after the transplantation procedure. To do this process, transplant diagnostics treatment is used. In addition, this transplant diagnostic is also used after the transplantation procedure to check whether any reactions happen after the organ implantation in the receptor body.
Growing awareness regarding the transplant diagnosis among patients undergoing organ transplantation further propels the market growth in this region. In Europe, organ transplantation improves patient survival and quality of life and positively impacts reducing cases of organ failure. Therefore, European Union (EU) has been conducting various programs regarding transplant diagnosis and how it helps in pre- and post-transplantation procedures. The rising adoption of technological developments in transplant diagnostics boosts the regional market growth. In addition, the growing R&D efforts by the market participants and increasing investments in transplant diagnostics are anticipated to result in regional market growth during the forecast period.
In addition, the growing healthcare expenditure, increasing investments in healthcare infrastructure and rising awareness about the benefits of early diagnosis and personalized medicine, the growing prevalence of infectious diseases, favorable government initiatives and policies, the growing public and private investments in research and development activities and increasing partnerships and collaborations between academic institutions and industry players across Europe further fuel growth rate of the European market.
However, the usage of refurbished medical devices for transplant diagnostics can still be witnessed in some parts of Europe, which is one of the major factors hindering the regional market growth. Furthermore, poor awareness levels among the public regarding organ transplantations and poor success rates in some of Europe's underdeveloped and developing countries further inhibit the growth rate of the European transplant diagnostics market. Furthermore, issues associated with infrastructure, high costs associated with the equipment required and lack of skilled professionals hamper transplant diagnostics market growth in Europe.
This research report on the Europe Transplant Diagnostics Market has been segmented & sub-segmented into the following categories.
By Technology:
Based on technology, the molecular assay segment had the major share of the European transplant diagnostics market in 2023.
By Product:
Segments such as consumables and reagents are estimated to account for the largest share of the European market during the forecast period.
By Application:
By Transplant Type:
By End-User:
By Country:
The European transplant diagnostics market accounted for a substantial share of the global market in 2022. The growing patient population suffering from chronic diseases and rising healthcare expenditure are favoring the market in the European region. European countries such as the UK, Germany, Spain, France, and Italy expect promising growth during the forecast period. Rising cases of kidney failure are another major factor boosting the transplant diagnostics market forward in Europe.
The UK transplant diagnostics market dominated the European region in 2022. The domination of the UK in the European market is anticipated to continue during the forecast period owing to the increasing adoption rate of transplantation procedures. Between 2021 to 2022, an estimated 3400 organ transplantation procedures were recorded in the United Kingdom. Factors such as strong healthcare infrastructure, large patient population and the growing investments by the UK government to conduct R&D to advance the field of transplant diagnostics majorly propel the UK market growth.
The German transplant diagnostics market is estimated to play a vital role in the European market during the forecast period. The increasing aging population requiring organ transplantation and growing awareness among the public regarding transplant diagnostics are promoting market growth in Germany. The presence of advanced healthcare systems, a large population and favorable policies from the German government to encourage innovation and growing focus from the German market participants to be at the forefront of developing new transplant diagnostics technologies primarily boost the growth rate of the German market.
France is another noteworthy regional market for transplant diagnostics and is anticipated to account for a considerable share of the European market during the forecast period. Well-developed healthcare system and many research institutions and companies involved in developing transplant diagnostics products and services drive the transplant diagnostics market in France.
Countries like Spain and Italy are expected to witness healthy growth during the forecast period.
KEY MARKET PLAYERS:
CareDx, Pacific Biosciences of California, Illumina, Thermo Fischer Scientific, GenDx, and Immucor are notable companies operating in the European transplant diagnostics market. In addition, major key players are partnering to develop advanced products and treatments in the transplanting process. For instance, Bio-Rad Laboratories announced the launch of a diagnostics transplant product line consisting of molecular standards and quality controls to European laboratories.
Frequently Asked Questions
The European transplant diagnostics market was valued at USD 1.13 bn in 2022.
The growing demand for organ transplantation, advancements in transplant diagnostics technology, growing healthcare expenditure and investment in healthcare infrastructure and rising awareness about the benefits of early diagnosis and personalized medicine primarily drive the growth of the European transplant diagnostics market.
Germany, France, UK, Spain, Italy, and the Netherlands are some of the major counties that control major share of the European market.
The high cost of transplant diagnostics procedures, regulatory challenges, and a shortage of donor organs are some of the key challenges to the European transplant diagnostics market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region